...
【24h】

Foreword: allergen immunotherapy.

机译:前言:过敏原免疫治疗。

获取原文
获取原文并翻译 | 示例
           

摘要

This year is the 100th anniversary of the first scientific publication on allergen immuno-therapy. Leonard Noon, the father of allergen immunotherapy, called it "prophylactic inoculation against hay fever."1 In his pioneering article, he acknowledged that Dunbar in Hamburg, Germany, through his animal experiments, provided the initial scientific understanding for sensitivity to pollens. Alexandre Besredka in Paris was the first to successfully perform allergen hyposensitization in animals,2 The foregoing scientific works formed the foundation for "prophylactic inoculation" against hay fever. However, the concept of prophylactic inoculation, ie, vaccination, was introduced to the Western medicine more than 100 years earlier in 1798 by Edward Jenner.3 Therefore, it is likely that Leonard Noon applied the principle and method of vaccination to hay fever. Vaccination is arguably the biggest discovery in modem medicine.
机译:今年是有关过敏原免疫疗法的第一本科学出版物发表100周年。变应原免疫疗法之父伦纳德·正午(Leonard Noon)称其为“预防花粉症的预防接种。” 1在他的开创性文章中,他承认,德国汉堡的邓巴(Dunbar)通过动物实验,提供了对花粉敏感性的初步科学理解。巴黎的亚历山大·贝斯雷德卡(Alexandre Besredka)是第一个成功地对动物进行过敏原超敏反应的国家。2上述科学工作为“预防接种花粉症”奠定了基础。但是,爱德华·詹纳(Edward Jenner)在1798年将预防接种的概念(即疫苗接种)引入了100多年前的西医中。3因此,伦纳德·诺恩(Leonard Noon)可能将接种的原理和方法应用于花粉热。疫苗接种可以说是现代医学中最大的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号